Search
Search Results
Found 21 items.
-
The new era of anticoagulation: factor XI and XII inhibitors
Published: 7 June 20231749PDF: 765 -
Allopurinol-induced acquired von Willebrand syndrome
Published: 25 October 20231451PDF: 137 -
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma
Published: 9 March 2023497PDF: 311 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024397PDF: 168 -
Is non-alcoholic fatty liver disease a prothrombotic risk factor?
Published: 19 May 2023463PDF: 154 -
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series
Published: 17 October 20222249PDF: 188 -
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life
Published: 22 April 2024245PDF: 54 -
Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications
Published: 3 May 2023937PDF: 176 -
Growing weapons to fight hemophilia
Published: 23 February 2023627PDF: 270 -
The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis
Published: 26 April 20221819PDF: 303 -
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?
Published: 3 August 20231152PDF: 404 -
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?
Published: 14 December 2022628PDF: 272 -
Importance of assessment of carotid plaques in the managementof acute ischemic stroke: floating intracarotid plaque
Published: 6 September 2023486PDF: 129 -
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review
Published: 16 May 2024268PDF: 100 -
Association between non-O blood type and early unexplained recurrent spontaneous abortion in women with and without inherited thrombophilia
Published: 14 November 20221006PDF: 178 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024247PDF: 111 -
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?
Published: 15 April 20221901PDF: 484 -
An ecological alliance against air pollution and cardiovascular disease
Published: 22 March 20221629PDF: 236 -
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art
Published: 4 September 2024492PDF: 106SUPPLEMENTARY MATERIAL: 75 -
It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders
Published: 3 August 2023951PDF: 162
1 - 21 of 21 items